257. Hepatic glycogenosis Clinical trials / Disease details

Clinical trials : 14 / Drugs : 28 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 8

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04930627 (ClinicalTrials.gov)	July 2021	11/6/2021	Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia	Evaluation of Efficacy and Safety of Empagliflozin in Treatment of Neutropenia in Patients With Glycogenosis Ib	Glucose 6 Phosphatase Deficiency	Drug: Empagliflozin	Children's Memorial Health Institute, Poland	Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw	Not yet recruiting	N/A	N/A	All	20	Phase 2	Poland
2	NCT04138251 (ClinicalTrials.gov)	June 20, 2019	20/6/2019	Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency	Evaluation of the Safety and Efficacy of Empagliflozin Administration as a Treatment for Neutropenia in Patients With Glycogenosis Type 1b and G6PC3 Deficiency	Glycogen Storage Disease Type I;Glucose 6 Phosphatase Deficiency	Drug: Empagliflozin	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Recruiting	1 Year	18 Years	All	5	Phase 2	Belgium